CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 155 enrolled
Drug / intervention
Bupivacainedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02777749
NCT02777749Phase 4Completed
CompareCT.gov

Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty

Columbia University·interventional·Posted May 19, 2016·Updated Mar 20, 2019

In Brief

A Phase 4 clinical trial evaluating Bupivacaine for Osteoarthritis. Completed, enrolled 155 participants across 1 site.

Detailed Summary

The objective of the study is to compare the efficacy of adductor canal blocks versus periarticular bupivacaine injections for pain management in total knee arthroplasty. This randomized clinical trial will compare outcomes between adductor canal blocks, periarticular bupivacaine injections, and periarticular liposomal bupivacaine injections. Results from this study will help determine the most appropriate perioperative pain management strategy for patients undergoing a total knee arthroplasty.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedMay 19, 2016
Enrollment StartJul 19, 2016
Primary CompletionSep 19, 2017
Study CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.1 years ago

Interventions

Bupivacainedrug

15 cc's of 0.5% bupivacaine or 50 cc's of 0.25% short-acting bupivacaine (SB), intramuscular injection